These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 31595560)
41. [Advance in studies on anti-tumor mechanism of matrine]. Guo LF; Tong SS; Yu JN; Xu XM Zhongguo Zhong Yao Za Zhi; 2013 Oct; 38(20):3409-12. PubMed ID: 24490544 [TBL] [Abstract][Full Text] [Related]
42. Matrine alkaloids modulating DNA damage repair in chemoresistant non-small cell lung cancer cells. Wang F; Liu J; Liao W; Zheng L; Qian S; Mao L BMC Cancer; 2024 Oct; 24(1):1283. PubMed ID: 39415176 [TBL] [Abstract][Full Text] [Related]
43. Matrine induced G0/G1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia (T-ALL) cells. Tetik Vardarlı A; Düzgün Z; Erdem C; Kaymaz BT; Eroglu Z; Çetintas VB Bosn J Basic Med Sci; 2018 May; 18(2):141-149. PubMed ID: 29045804 [TBL] [Abstract][Full Text] [Related]
44. Matrine inhibits ovarian cancer cell viability and promotes apoptosis by regulating the ERK/JNK signaling pathway via p38MAPK. Liang X; Ju J Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786627 [TBL] [Abstract][Full Text] [Related]
45. Effects of matrine on HepG2 cell proliferation and expression of tumor relevant proteins in vitro. Qin XG; Hua Z; Shuang W; Wang YH; Cui YD Pharm Biol; 2010 Mar; 48(3):275-81. PubMed ID: 20645813 [TBL] [Abstract][Full Text] [Related]
46. A novel miR-34a target, protein kinase D1, stimulates cancer stemness and drug resistance through GSK3/β-catenin signaling in breast cancer. Kim do Y; Park EY; Chang E; Kang HG; Koo Y; Lee EJ; Ko JY; Kong HK; Chun KH; Park JH Oncotarget; 2016 Mar; 7(12):14791-802. PubMed ID: 26895471 [TBL] [Abstract][Full Text] [Related]
47. [Matrine suppresses stemness of hepatocellular carcinoma cells by regulating β-catenin signaling pathway]. Dai M; Cai Z; Chen N; Li J; Wen J; Tan L; Guo D Nan Fang Yi Ke Da Xue Xue Bao; 2019 Oct; 39(10):1239-1245. PubMed ID: 31801708 [TBL] [Abstract][Full Text] [Related]
48. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells. Huang Y; Luo F IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145 [TBL] [Abstract][Full Text] [Related]
49. Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapy. Xu J; Zhao X; Liang X; Guo D; Wang J; Wang Q; Tang X Sci Adv; 2024 Sep; 10(38):eadp0334. PubMed ID: 39292784 [TBL] [Abstract][Full Text] [Related]
51. Matrine induces mitochondrial apoptosis in cisplatin-resistant non-small cell lung cancer cells via suppression of β-catenin/survivin signaling. Wang HQ; Jin JJ; Wang J Oncol Rep; 2015 May; 33(5):2561-6. PubMed ID: 25760455 [TBL] [Abstract][Full Text] [Related]
52. Matrine‑induced apoptosis in Hep3B cells via the inhibition of MDM2. Zhou N; Li J; Li T; Chen G; Zhang Z; Si Z Mol Med Rep; 2017 Jan; 15(1):442-450. PubMed ID: 27959389 [TBL] [Abstract][Full Text] [Related]
53. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice. Chen L; Chen L; Wan L; Huo Y; Huang J; Li J; Lu J; Xin B; Yang Q; Guo C Oncol Rep; 2019 Aug; 42(2):479-494. PubMed ID: 31233199 [TBL] [Abstract][Full Text] [Related]
54. Matrine induces senescence of human glioblastoma cells through suppression of the IGF1/PI3K/AKT/p27 signaling pathway. Zhou W; Wang J; Qi Q; Feng Z; Huang B; Chen A; Zhang D; Li W; Zhang Q; Bjerkvig R; Li X; Wang J Cancer Med; 2018 Sep; 7(9):4729-4743. PubMed ID: 30079478 [TBL] [Abstract][Full Text] [Related]
55. Matrine inhibits proliferation and induces apoptosis of the androgen‑independent prostate cancer cell line PC-3. Zhang P; Wang Z; Chong T; Ji Z Mol Med Rep; 2012 Mar; 5(3):783-7. PubMed ID: 22159447 [TBL] [Abstract][Full Text] [Related]
56. Matrine suppresses proliferation and induces apoptosis in human cholangiocarcinoma cells through suppression of JAK2/STAT3 signaling. Yang N; Han F; Cui H; Huang J; Wang T; Zhou Y; Zhou J Pharmacol Rep; 2015 Apr; 67(2):388-93. PubMed ID: 25712669 [TBL] [Abstract][Full Text] [Related]
57. Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells. Li Q; Huang H; He Z; Sun Y; Tang Y; Shang X; Wang C Sci China Life Sci; 2018 May; 61(5):550-558. PubMed ID: 29119376 [TBL] [Abstract][Full Text] [Related]
58. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway. Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282 [TBL] [Abstract][Full Text] [Related]
59. Matrine suppresses cell growth of diffuse large B-cell lymphoma via inhibiting CaMKIIγ/c-Myc/CDK6 signaling pathway. Gu J; Wang X; Zhang L; Xiang J; Li J; Chen Z; Zhang Y; Chen J; Shen J BMC Complement Med Ther; 2021 Jun; 21(1):163. PubMed ID: 34088288 [TBL] [Abstract][Full Text] [Related]
60. Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking. Sun X; Xu C; Xiao G; Meng J; Wang J; Tang SC; Qin S; Du N; Li G; Ren H; Liu D Int J Mol Med; 2018 Apr; 41(4):1967-1975. PubMed ID: 29336465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]